Recruiting nowN/AAges 18 Years and up
Pre-operative Hypofractionated Proton Therapy
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT05917301 on ClinicalTrials.gov ↗
Conditions studied
Soft Tissue Sarcoma
What it tests
- hypofractionationradiation
Where it's running1 site
- Recruiting now
Sibley Memorial Hospital
Washington D.C., District of Columbia 20016
- Curtiland Deville, MD(contact)202-537-4788[email protected]
- Dana Kaplin(contact)410-614-3950[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Adult patients (≥18 years of age) * Patients with primary or locally recurrent extremity or truncal soft tissue sarcoma * WHO/ECOG status ≤2 Exclusion Criteria: * History of prior local radiation therapy * Inability to tolerate treatment position for duration of simulation or treatment * Tumor originating in retroperitoneal location * Patients planned for systemic therapy including chemotherapy, targeted agents, and immunotherapy * Co-existing malignancy or treated malignancy in the last 2 years expected to limit life expectancy; does not include completely resected cutaneous basal cell carcinoma, squamous cell carcinoma, in situ breast or cervical malignancies, or other pathologies at the discretion of the investigators. * Confirmed pregnancy.
Updated 2026-04-17 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.